GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
IM-MV 18-009_000 Universitair Medisch Centrum Utrecht Clinical testing of KITE-585, an autologous cellular immunotherapy composed of T cells genetically modified ex vivo to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumor cells Ontwerpbesluit genomen